Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
Dr. Armand Daccache with the Yale Eye Center briefly reviews diabetic retinopathy. References and Resources National Eye Institute: Diabetic Retinopathy Sponsored by The Doctor’s Channel
Dr. Ron Adelman, MD, MPH, FACS at the Yale Eye Center reviews the results of a large study by the National Eye Institute (AREDS) that proposed an effective…
Dr. Susan Hall Forster with the Yale Eye Center talks about her work providing glaucoma treatment and screening to the disadvantaged population in Connecticut. References and Resources The…
James C. Tsai, MD, MBA, FACS, Chairman of the Department of Ophthalmology and Visual Science at the Yale Eye Center, goes over the relationship between glaucoma, ocular hypertension,…
NEW YORK (Reuters Health) – On screening colonoscopy, polyps greater than 9 mm in diameter are more likely to be detected in black individuals than in their white…
NEW YORK (Reuters Health) – The results of a new study indicate that 80% of cancer patients undergoing radiation therapy do not use medications to combat pain. Many…
NEW YORK (Reuters Health) – Even in the absence of clinical stroke, atrial fibrillation (AF) is associated with impaired cognitive function and reduced hippocampal volume, according to findings…
NEW YORK (Reuters Health) – Elective cesarean section is associated with a lower rate of mother-to-child transmission of hepatitis B virus (HBV) than is vaginal delivery, according to…
NEW YORK (Reuters Health) – With the introduction of more intensive medical therapy, revascularization for asymptomatic carotid stenosis is likely to benefit less than 5% of patients, according…
NEW YORK (Reuters Health) – While raloxifene and tamoxifen are broadly similar in reducing breast cancer risk, raloxifene appears also to lower the odds of developing endometrial cancer,…
